<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34417184</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">2375-2548</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>34</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Science advances</Title><ISOAbbreviation>Sci Adv</ISOAbbreviation></Journal><ArticleTitle>Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">eabi6896</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1126/sciadv.abi6896</ELocationID><Abstract><AbstractText>Spinal and bulbar muscular atrophy (SBMA) is an X-linked, adult-onset neuromuscular condition caused by an abnormal polyglutamine (polyQ) tract expansion in androgen receptor (AR) protein. SBMA is a disease with high unmet clinical need. Recent studies have shown that mutant AR-altered transcriptional activity is key to disease pathogenesis. Restoring the transcriptional dysregulation without affecting other AR critical functions holds great promise for the treatment of SBMA and other AR-related conditions; however, how this targeted approach can be achieved and translated into a clinical application remains to be understood. Here, we characterized the role of AR isoform 2, a naturally occurring variant encoding a truncated AR lacking the polyQ-harboring domain, as a regulatory switch of AR genomic functions in androgen-responsive tissues. Delivery of this isoform using a recombinant adeno-associated virus vector type 9 resulted in amelioration of the disease phenotype in SBMA mice by restoring polyQ AR-dysregulated transcriptional activity.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Wooi F</ForeName><Initials>WF</Initials><Identifier Source="ORCID">0000-0002-1238-3040</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forouhan</LastName><ForeName>Mitra</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Thomas C</ForeName><Initials>TC</Initials><Identifier Source="ORCID">0000-0002-3313-7631</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dabney</LastName><ForeName>Jesse</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8893-1245</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellerington</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Speciale</LastName><ForeName>Alfina A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0001-9728-254X</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manzano</LastName><ForeName>Raquel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-7477-8742</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lieto</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sangha</LastName><ForeName>Gavinda</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-8433-8994</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Subhashis</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Concei&#xe7;&#xe3;o</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8362-0237</Identifier></Author><Author ValidYN="Y"><LastName>Cravo</LastName><ForeName>Lara</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-0815-0869</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biscans</LastName><ForeName>Annabelle</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9953-9265</Identifier><AffiliationInfo><Affiliation>RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roux</LastName><ForeName>Lo&#xef;c</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-6099-0427</Identifier><AffiliationInfo><Affiliation>Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pourshafie</LastName><ForeName>Naemeh</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Neurogenetics Branch, National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grunseich</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neurogenetics Branch, National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duguez</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6510-5426</Identifier><AffiliationInfo><Affiliation>Northern Ireland Centre for Stratified Medicine, Biomedical Sciences Research Institute, Londonderry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khvorova</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pennuto</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8634-0767</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Venetian Institute of Molecular Medicine (VIMM), Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cortes</LastName><ForeName>Constanza J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Duke Center for Neurodegeneration and Neurotherapeutics, Duke University School of Medicine, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>La Spada</LastName><ForeName>Albert R</ForeName><Initials>AR</Initials><Identifier Source="ORCID">0000-0001-6151-2964</Identifier><AffiliationInfo><Affiliation>Departments of Pathology and Laboratory Medicine, Neurology, and Biological Chemistry and the UCI Institute for Neurotherapeutics, University of California, Irvine, Irvine, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischbeck</LastName><ForeName>Kenneth H</ForeName><Initials>KH</Initials><Identifier Source="ORCID">0000-0002-8316-6895</Identifier><AffiliationInfo><Affiliation>Neurogenetics Branch, National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wood</LastName><ForeName>Matthew J A</ForeName><Initials>MJA</Initials><Identifier Source="ORCID">0000-0002-5436-6011</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinaldi</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-8307-6638</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, University of Oxford, Oxford, UK. carlo.rinaldi@paediatrics.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/N024850/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 NS100023</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 NS122140</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sci Adv</MedlineTA><NlmUniqueID>101653440</NlmUniqueID><ISSNLinking>2375-2548</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020033">Protein Isoforms</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011944">Receptors, Androgen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="Y">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015316" MajorTopicYN="N">Genetic Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020033" MajorTopicYN="N">Protein Isoforms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011944" MajorTopicYN="Y">Receptors, Androgen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>21</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34417184</ArticleId><ArticleId IdType="pmc">PMC8378820</ArticleId><ArticleId IdType="doi">10.1126/sciadv.abi6896</ArticleId><ArticleId IdType="pii">7/34/eabi6896</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>La Spada A. R., Wilson E. M., Lubahn D. B., Harding A. E., Fischbeck K. H., Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77&#x2013;79 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew S. E., Goldberg Y. P., Hayden M. R., Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum. Mol. Genet. 6, 2005&#x2013;2010 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9328463</ArticleId></ArticleIdList></Reference><Reference><Citation>Chahin N., Klein C., Mandrekar J., Sorenson E., Natural history of spinal-bulbar muscular atrophy. Neurology 70, 1967&#x2013;1971 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18490617</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardiner S. L., Boogaard M. W., Trompet S., De Mutsert R., Rosendaal F. R., Gussekloo J., Jukema J. W., Roos R. A. C., Aziz N. A., Prevalence of carriers of intermediate and pathological polyglutamine disease-associated alleles among large population-based cohorts. JAMA Neurol. 76, 650&#x2013;656 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6563569</ArticleId><ArticleId IdType="pubmed">30933216</ArticleId></ArticleIdList></Reference><Reference><Citation>Laskaratos A., Breza M., Karadima G., Koutsis G., Wide range of reduced penetrance alleles in spinal and bulbar muscular atrophy: A model-based approach. J. Med. Genet. 58, 385&#x2013;391 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32571900</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Sch&#xfc;tz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R. M., The nuclear receptor superfamily: The second decade. Cell 83, 835&#x2013;839 (1995).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6159888</ArticleId><ArticleId IdType="pubmed">8521507</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas-Herald A. K., Alves-Lopes R., Montezano A. C., Ahmed S. F., Touyz R. M., Genomic and non-genomic effects of androgens in the cardiovascular system: Clinical implications. Clin. Sci. 131, 1405&#x2013;1418 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5736922</ArticleId><ArticleId IdType="pubmed">28645930</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C., Rinaldi C., Fischbeck K. H., Spinal and bulbar muscular atrophy: Pathogenesis and clinical management. Oral Dis. 20, 6&#x2013;9 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4284073</ArticleId><ArticleId IdType="pubmed">23656576</ArticleId></ArticleIdList></Reference><Reference><Citation>Mhatre A. N., Trifiro M. A., Kaufman M., Kazemi-Esfarjani P., Figlewicz D., Rouleau G., Pinsky L., Reduced transcriptional regulatory competence of the androgen receptor in X&#x2013;linked spinal and bulbar muscular atrophy. Nat. Genet. 5, 184&#x2013;188 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8252045</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman A. P., Harmison G., Strand A. D., Olson J. M., Fischbeck K. H., Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum. Mol. Genet. 11, 1967&#x2013;1976 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12165558</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfini G., Pigino G., Szebenyi G., You Y., Pollema S., Brady S. T., JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat. Neurosci. 9, 907&#x2013;916 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16751763</ArticleId></ArticleIdList></Reference><Reference><Citation>Szebenyi G., Morfini G. A., Babcock A., Gould M., Selkoe K., Stenoien D. L., Young M., Faber P. W., MacDonald M. E., McPhaul M. J., Brady S. T., Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 40, 41&#x2013;52 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14527432</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S., Harmison G. G., Meyertholen K., Pennuto M., Burnett B. G., Fischbeck K. H., Mitochondrial abnormalities in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 18, 27&#x2013;42 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2644643</ArticleId><ArticleId IdType="pubmed">18824496</ArticleId></ArticleIdList></Reference><Reference><Citation>McCampbell A., Taylor J. P., Taye A. A., Robitschek J., Li M., Walcott J., Merry D., Chai Y., Paulson H., Sobue G., Fischbeck K. H., CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet. 9, 2197&#x2013;2202 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10958659</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua J. P., Reddy S. L., Yu Z., Giorgetti E., Montie H. L., Mukherjee S., Higgins J., McEachin R. C., Robins D. M., Merry D. E., I&#xf1;iguez-Lluh&#xed; J. A., Lieberman A. P., Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor&#x2013;mediated disease. J. Clin. Invest. 125, 831&#x2013;845 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4319414</ArticleId><ArticleId IdType="pubmed">25607844</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano R., Sorar&#xfa; G., Grunseich C., Fratta P., Zuccaro E., Pennuto M., Rinaldi C., Beyond motor neurons: Expanding the clinical spectrum in Kennedy&#x2019;s disease. J. Neurol. Neurosurg. Psychiatry 89, 808&#x2013;812 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6204939</ArticleId><ArticleId IdType="pubmed">29353237</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky N. B., Pennuto M., Smith R. B., Palazzolo I., Moore J., Nie Z., Neale G., Taylor J. P., Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron 67, 936&#x2013;952 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3514079</ArticleId><ArticleId IdType="pubmed">20869592</ArticleId></ArticleIdList></Reference><Reference><Citation>Banno H., Katsuno M., Suzuki K., Takeuchi Y., Kawashima M., Suga N., Takamori M., Ito M., Nakamura T., Matsuo K., Yamada S., Oki Y., Adachi H., Minamiyama M., Waza M., Atsuta N., Watanabe H., Fujimoto Y., Nakashima T., Tanaka F., Doyu M., Sobue G., Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann. Neurol. 65, 140&#x2013;150 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19259967</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuno M., Banno H., Suzuki K., Takeuchi Y., Kawashima M., Yabe I., Sasaki H., Aoki M., Morita M., Nakano I., Kanai K., Ito S., Ishikawa K., Mizusawa H., Yamamoto T., Tsuji S., Hasegawa K., Shimohata T., Nishizawa M., Miyajima H., Kanda F., Watanabe Y., Nakashima K., Tsujino A., Yamashita T., Uchino M., Fujimoto Y., Tanaka F., Sobue G.; Japan SBMA Interventional Trial for TAP-144-SR (JASMITT) study group , Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): A multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 9, 875&#x2013;884 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20691641</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Rhodes L. E., Kokkinis A. D., White M. J., Watts C. A., Auh S., Jeffries N. O., Shrader J. A., Lehky T. J., Li L., Ryder J. E., Levy E. W., Solomon B. I., Harris-Love M. O., La Pean A., Schindler A. B., Chen C., Di Prospero N. A., Fischbeck K. H., Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: A randomised placebo-controlled trial. Lancet Neurol. 10, 140&#x2013;147 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3056353</ArticleId><ArticleId IdType="pubmed">21216197</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman A. P., Yu Z., Murray S., Peralta R., Low A., Guo S., Yu X. X., Cortes C. J., Bennett C. F., Monia B. P., La Spada A. R., Hung G., Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep. 7, 774&#x2013;784 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4356525</ArticleId><ArticleId IdType="pubmed">24746732</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Chang Y.-J., Yu I.-C., Yeh S., Wu C.-C., Miyamoto H., Merry D. E., Sobue G., Chen L.-M., Chang S.-S., Chang C., ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nat. Med. 13, 348&#x2013;353 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17334372</ArticleId></ArticleIdList></Reference><Reference><Citation>Badders N. M., Korff A., Miranda H. C., Vuppala P. K., Smith R. B., Winborn B. J., Quemin E. R., Sopher B. L., Dearman J., Messing J., Kim N. C., Moore J., Freibaum B. D., Kanagaraj A. P., Fan B., Tillman H., Chen P.-C., Wang Y., Freeman B. B., Li Y., Kim H. J., La Spada A. R., Taylor J. P., Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy. Nat. Med. 24, 427&#x2013;437 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5975249</ArticleId><ArticleId IdType="pubmed">29505030</ArticleId></ArticleIdList></Reference><Reference><Citation>Bott L. C., Badders N. M., Chen K., Harmison G. G., Bautista E., Shih C. C.-Y., Katsuno M., Sobue G., Taylor J. P., Dantuma N. P., Fischbeck K. H., Rinaldi C., A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy. Hum. Mol. Genet. 25, 1979&#x2013;1989 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5062587</ArticleId><ArticleId IdType="pubmed">26962150</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahrens-Fath I., Politz O., Geserick C., Haendler B., Androgen receptor function is modulated by the tissue-specific AR45 variant. FEBS J. 272, 74&#x2013;84 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15634333</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss B., Faus H., Haendler B., Phylogenetic conservation of the androgen receptor AR45 variant form in placental mammals. Gene 399, 105&#x2013;111 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17574777</ArticleId></ArticleIdList></Reference><Reference><Citation>Centenera M. M., Harris J. M., Tilley W. D., Butler L. M., Minireview: The contribution of different androgen receptor domains to receptor dimerization and signaling. Mol. Endocrinol. 22, 2373&#x2013;2382 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18617596</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfleger K. D. G., Seeber R. M., Eidne K. A., Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein interactions. Nat. Protoc. 1, 337&#x2013;345 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17406254</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborn M. F., Khvorova A., Improving siRNA delivery In Vivo through lipid conjugation. Nucleic Acid Ther. 28, 128&#x2013;136 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5994667</ArticleId><ArticleId IdType="pubmed">29746209</ArticleId></ArticleIdList></Reference><Reference><Citation>Segawa T., Nau M. E., Xu L. L., Chilukuri R. N., Makarem M., Zhang W., Petrovics G., Sesterhenn I. A., McLeod D. G., Moul J. W., Vahey M., Srivastava S., Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells. Oncogene 21, 8749&#x2013;8758 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12483528</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni W., Chen S., Qiao K., Wang N., Wu Z.-Y., Borchelt D. R. Eds, Genotype-phenotype correlation in chinese patients with spinal and bulbar muscular atrophy. PLOS ONE 10, e0122279 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4374859</ArticleId><ArticleId IdType="pubmed">25811990</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amato N. C., Gordon M. A., Babbs B., Spoelstra N. S., Carson Butterfield K. T., Torkko K. C., Phan V. T., Barton V. N., Rogers T. J., Sartorius C. A., Elias A., Gertz J., Jacobsen B. M., Richer J. K., Cooperative dynamics of AR and ER activity in breast cancer. Mol. Cancer Res. 14, 1054&#x2013;1067 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5107172</ArticleId><ArticleId IdType="pubmed">27565181</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennuto M., Rinaldi C., From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet? Mol. Cell. Endocrinol. 465, 113&#x2013;121 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28688959</ArticleId></ArticleIdList></Reference><Reference><Citation>Chivet M., Marchioretti C., Pirazzini M., Piol D., Scaramuzzino C., Polanco M. J., Romanello V., Zuccaro E., Parodi S., D&#x2019;Antonio M., Rinaldi C., Sambataro F., Pegoraro E., Soraru G., Pandey U. B., Sandri M., Basso M., Pennuto M., Polyglutamine-expanded androgen receptor alteration of skeletal muscle homeostasis and myonuclear aggregation are affected by sex, age and muscle metabolism. Cells 9, 325 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7072234</ArticleId><ArticleId IdType="pubmed">32019272</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourshafie N., Lee P. R., Chen K.-L., Harmison G. G., Bott L. C., Katsuno M., Sobue G., Burnett B. G., Fischbeck K. H., Rinaldi C., MIR-298 counteracts mutant androgen receptor toxicity in spinal and bulbar muscular atrophy. Mol. Ther. 24, 937&#x2013;945 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4881766</ArticleId><ArticleId IdType="pubmed">26755334</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray S. J., Woodard K. T., Samulski R. J., Viral vectors and delivery strategies for CNS gene therapy. Ther. Deliv. 1, 517&#x2013;534 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4509525</ArticleId><ArticleId IdType="pubmed">22833965</ArticleId></ArticleIdList></Reference><Reference><Citation>Giorgetti E., Yu Z., Chua J. P., Shimamura R., Zhao L., Zhu F., Venneti S., Pennuto M., Guan Y., Hung G., Lieberman A. P., Rescue of metabolic alterations in AR113Q skeletal muscle by peripheral androgen receptor gene silencing. Cell Rep. 17, 125&#x2013;136 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5076565</ArticleId><ArticleId IdType="pubmed">27681426</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocchi A., Milioto C., Parodi S., Armirotti A., Borgia D., Pellegrini M., Urciuolo A., Molon S., Morbidoni V., Marabita M., Romanello V., Gatto P., Blaauw B., Bonaldo P., Sambataro F., Robins D. M., Lieberman A. P., Sorar&#xf9; G., Vergani L., Sandri M., Pennuto M., Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet. Acta Neuropathol. 132, 127&#x2013;144 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4911374</ArticleId><ArticleId IdType="pubmed">26971100</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath S. R., Yu Z., Gipson T. A., Marsh G. B., Yoshidome E., Robins D. M., Todi S. V., Housman D. E., Lieberman A. P., Androgen receptor polyglutamine expansion drives age-dependent quality control defects and muscle dysfunction. J. Clin. Invest. 128, 3630&#x2013;3641 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6063498</ArticleId><ArticleId IdType="pubmed">29809168</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik B., Devine H., Patani R., La Spada A. R., Hanna M. G., Greensmith L., Gene expression analysis reveals early dysregulation of disease pathways and links Chmp7 to pathogenesis of spinal and bulbar muscular atrophy. Sci. Rep. 9, 3539 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6401132</ArticleId><ArticleId IdType="pubmed">30837566</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes C. J., Ling S.-C., Guo L. T., Hung G., Tsunemi T., Ly L., Tokunaga S., Lopez E., Sopher B. L., Bennett C. F., Shelton G. D., Cleveland D. W., La Spada A. R., Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron 82, 295&#x2013;307 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4096235</ArticleId><ArticleId IdType="pubmed">24742458</ArticleId></ArticleIdList></Reference><Reference><Citation>Sopher B. L., La Spada A. R., Efficient recombination-based methods for bacterial artificial chromosome fusion and mutagenesis. Gene 371, 136&#x2013;143 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16487669</ArticleId></ArticleIdList></Reference><Reference><Citation>Murrey D. A., Naughton B. J., Duncan F. J., Meadows A. S., Ware T. A., Campbell K. J., Bremer W. G., Walker C. M., Goodchild L., Bolon B., La Perle K., Flanigan K. M., McBride K. L., McCarty D. M., Fu H., Feasibility and safety of systemic rAAV9-hNAGLU delivery for treating mucopolysaccharidosis IIIB: Toxicology, biodistribution, and immunological assessments in primates. Hum. Gene. Ther. Clin. Dev. 25, 72&#x2013;84 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4124586</ArticleId><ArticleId IdType="pubmed">24720466</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J.-J., Lai K.-P., Chuang K.-H., Chang P., Yu I.-C., Lin W.-J., Chang C., Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-&#x3b1; expression. J. Clin. Invest. 119, 3739&#x2013;3751 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2786793</ArticleId><ArticleId IdType="pubmed">19907077</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang Y., Myers M., Brown M., Formation of the androgen receptor transcription complex. Mol. Cell 9, 601&#x2013;610 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11931767</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranda A., Pascual A., Nuclear hormone receptors and gene expression. Physiol. Rev. 81, 1269&#x2013;1304 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11427696</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyquist M. D., Dehm S. M., Interplay between genomic alterations and androgen receptor signaling during prostate cancer development and progression. Horm. Cancer 4, 61&#x2013;69 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3957092</ArticleId><ArticleId IdType="pubmed">23307762</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadiminty N., Tummala R., Liu C., Lou W., Evans C. P., Gao A. C., NF-&#x3ba;B2/p52:c-Myc:hnRNPA1 pathway regulates expression of androgen receptor splice variants and enzalutamide sensitivity in prostate cancer. Mol. Cancer Ther. 14, 1884&#x2013;1895 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4529751</ArticleId><ArticleId IdType="pubmed">26056150</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao S., Zhan Y., Dong Y., Emerging data on androgen receptor splice variants in prostate cancer. Endocr. Relat. Cancer 23, T199&#x2013;T210 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5107136</ArticleId><ArticleId IdType="pubmed">27702752</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehm S. M., Schmidt L. J., Heemers H. V., Vessella R. L., Tindall D. J., Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance. Cancer Res. 68, 5469&#x2013;5477 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2663383</ArticleId><ArticleId IdType="pubmed">18593950</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu R., Dunn T. A., Wei S., Isharwal S., Veltri R. W., Humphreys E., Han M., Partin A. W., Vessella R. L., Isaacs W. B., Bova G. S., Luo J., Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer. Cancer Res. 69, 16&#x2013;22 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2614301</ArticleId><ArticleId IdType="pubmed">19117982</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S., Sprenger C. C. T., Vessella R. L., Haugk K., Soriano K., Mostaghel E. A., Page S. T., Coleman I. M., Nguyen H. M., Sun H., Nelson P. S., Plymate S. R., Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant. J. Clin. Invest. 120, 2715&#x2013;2730 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2912187</ArticleId><ArticleId IdType="pubmed">20644256</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippakopoulos P., Picaud S., Mangos M., Keates T., Lambert J. P., Barsyte-Lovejoy D., Felletar I., Volkmer R., M&#xfc;ller S., Pawson T., Gingras A. C., Arrowsmith C. H., Knapp S., Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149, 214&#x2013;231 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3326523</ArticleId><ArticleId IdType="pubmed">22464331</ArticleId></ArticleIdList></Reference><Reference><Citation>Morini&#xe8;re J., Rousseaux S., Steuerwald U., Soler-L&#xf3;pez M., Curtet S., Vitte A. L., Govin J., Gaucher J., Sadoul K., Hart D. J., Krijgsveld J., Khochbin S., M&#xfc;ller C. W., Petosa C., Cooperative binding of two acetylation marks on a histone tail by a single bromodomain. Nature 461, 664&#x2013;668 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19794495</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Vakoc C. R., The mechanisms behind the therapeutic activity of BET bromodomain inhibition. Mol. Cell 54, 728&#x2013;736 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4236231</ArticleId><ArticleId IdType="pubmed">24905006</ArticleId></ArticleIdList></Reference><Reference><Citation>Asangani I. A., Dommeti V. L., Wang X., Malik R., Cieslik M., Yang R., Escara-Wilke J., Wilder-Romans K., Dhanireddy S., Engelke C., Iyer M. K., Jing X., Wu Y. M., Cao X., Qin Z. S., Wang S., Feng F. Y., Chinnaiyan A. M., Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer. Nature 510, 278&#x2013;282 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4075966</ArticleId><ArticleId IdType="pubmed">24759320</ArticleId></ArticleIdList></Reference><Reference><Citation>Urbanucci A., Barfeld S. J., Kyt&#xf6;l&#xe4; V., Itkonen H. M., Coleman I. M., Vod&#xe1;k D., Sj&#xf6;blom L., Sheng X., Tolonen T., Minner S., Burdelski C., Kivinummi K. K., Kohvakka A., Kregel S., Takhar M., Alshalalfa M., Davicioni E., Erho N., Lloyd P., Karnes R. J., Ross A. E., Schaeffer E. M., Vander Griend D. J., Knapp S., Corey E., Feng F. Y., Nelson P. S., Saatcioglu F., Knudsen K. E., Tammela T. L. J., Sauter G., Schlomm T., Nykter M., Visakorpi T., Mills I. G., Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer. Cell Rep. 19, 2045&#x2013;2059 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5675034</ArticleId><ArticleId IdType="pubmed">28591577</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Tai P. W. L., Gao G., Adeno-associated virus vector as a platform for gene therapy delivery. Nat. Rev. Drug Discov. 18, 358&#x2013;378 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6927556</ArticleId><ArticleId IdType="pubmed">30710128</ArticleId></ArticleIdList></Reference><Reference><Citation>High-dose AAV gene therapy deaths. Nat. Biotechnol. 38, 910 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32760031</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.-H., Shin J.-H., Park K.-P., Kim I.-J., Kim C.-M., Lim J.-G., Choi Y.-C., Kim D.-S., Phenotypic variability in Kennedy&#x2019;s disease: Implication of the early diagnostic features. Acta Neurol. Scand. 112, 57&#x2013;63 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15932358</ArticleId></ArticleIdList></Reference><Reference><Citation>Chahin N., Sorenson E. J., Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis. Muscle Nerve 40, 126&#x2013;129 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19533663</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorar&#xf9; G., D&#x2019;Ascenzo C., Polo A., Palmieri A., Baggio L., Vergani L., Gellera C., Moretto G., Pegoraro E., Angelini C., Spinal and bulbar muscular atrophy: Skeletal muscle pathology in male patients and heterozygous females. J. Neurol. Sci. 264, 100&#x2013;105 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">17854832</ArticleId></ArticleIdList></Reference><Reference><Citation>Malena A., Pennuto M., Tezze C., Querin G., D&#x2019;Ascenzo C., Silani V., Cenacchi G., Scaramozza A., Romito S., Morandi L., Pegoraro E., Russell A. P., Sorar&#xf9; G., Vergani L., Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy. Acta Neuropathol. 126, 109&#x2013;121 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23644820</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I., Stack C., Kong L., Musaro A., Adachi H., Katsuno M., Sobue G., Taylor J. P., Sumner C. J., Fischbeck K. H., Pennuto M., Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron 63, 316&#x2013;328 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2735765</ArticleId><ArticleId IdType="pubmed">19679072</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambataro F., Pennuto M., Cell-autonomous and non-cell-autonomous toxicity in polyglutamine diseases. Prog. Neurobiol. 97, 152&#x2013;172 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22061202</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z., Dadgar N., Albertelli M., Gruis K., Jordan C., Robins D. M., Lieberman A. P., Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J. Clin. Invest. 116, 2663&#x2013;2672 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1564432</ArticleId><ArticleId IdType="pubmed">16981011</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldi C., Bott L. C., Chen K.-I., Harmison G. G., Katsuno M., Sobue G., Pennuto M., Fischbeck K. H., Insulinlike growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy. Mol. Med. 18, 1261&#x2013;1268 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3521783</ArticleId><ArticleId IdType="pubmed">22952056</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldi C., Bott L. C., Fischbeck K. H., Muscle matters in kennedy&#x2019;s disease. Neuron 82, 251&#x2013;253 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4086161</ArticleId><ArticleId IdType="pubmed">24742452</ArticleId></ArticleIdList></Reference><Reference><Citation>Colella P., Sellier P., Costa Verdera H., Puzzo F., van Wittenberghe L., Guerchet N., Daniele N., Gjata B., Marmier S., Charles S., Simon Sola M., Ragone I., Leborgne C., Collaud F., Mingozzi F., AAV gene transfer with tandem promoter design prevents anti-transgene immunity and provides persistent efficacy in neonate pompe mice. Mol. Ther. Methods Clin. Dev. 12, 85&#x2013;101 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6299151</ArticleId><ArticleId IdType="pubmed">30581888</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla G. C., Plaga A. R., Shankar E., Gupta S., Androgen receptor-related diseases: What do we know? Andrology 4, 366&#x2013;381 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26991422</ArticleId></ArticleIdList></Reference><Reference><Citation>Chivet M., Marchioretti C., Pirazzini M., Piol D., Scaramuzzino C., Polanco J., Nath S., Zuccaro E., Nogara L., Canato M., Marcucci L., Parodi S., Romanello V., Armani A., D&#x2019;Antonio M., Sambataro F., Dassi E., Pegoraro E., Sorar&#xf9; G., Rinaldi C., Lieberman A., Blaauw B., Sandri M., Basso M., Pennuto M., Polyglutamine-expanded androgen receptor disrupts muscle triad, calcium dynamics and the excitation-contraction coupling gene expression program. bioRxiv, 618405 (2019).</Citation></Reference><Reference><Citation>Grunseich C., Zukosky K., Kats I. R., Ghosh L., Harmison G. G., Bott L. C., Rinaldi C., Chen K.-L., Chen G., Boehm M., Fischbeck K. H., Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients. Neurobiol. Dis. 70, 12&#x2013;20 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4172362</ArticleId><ArticleId IdType="pubmed">24925468</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt D., Wilson M. D., Spyrou C., Brown G. D., Hadfield J., Odom D. T., ChIP-seq: Using high-throughput sequencing to discover protein-DNA interactions. Methods 48, 240&#x2013;248 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4052679</ArticleId><ArticleId IdType="pubmed">19275939</ArticleId></ArticleIdList></Reference><Reference><Citation>Burger K., Schlackow M., Gullerova M., Tyrosine kinase c-Abl couples RNA polymerase II transcription to DNA double-strand breaks. Nucleic Acids Res. 47, 3467&#x2013;3484 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6468493</ArticleId><ArticleId IdType="pubmed">30668775</ArticleId></ArticleIdList></Reference><Reference><Citation>Biscans A., Haraszti R. A., Echeverria D., Miller R., Didiot M.-C., Nikan M., Roux L., Aronin N., Khvorova A., Hydrophobicity of lipid-conjugated siRNAs predicts productive loading to small extracellular vesicles. Mol. Ther. 26, 1520&#x2013;1528 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5986735</ArticleId><ArticleId IdType="pubmed">29699940</ArticleId></ArticleIdList></Reference><Reference><Citation>Haraszti R. A., Roux L., Coles A. H., Turanov A. A., Alterman J. F., Echeverria D., Godinho B. M. D. C., Aronin N., Khvorova A., 5&#x384;-Vinylphosphonate improves tissue accumulation and efficacy of conjugated siRNAs in vivo. Nucleic Acids Res. 45, 7581&#x2013;7592 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5570069</ArticleId><ArticleId IdType="pubmed">28591791</ArticleId></ArticleIdList></Reference><Reference><Citation>Ewels P., Magnusson M., Lundin S., K&#xe4;ller M., MultiQC: Summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047&#x2013;3048 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5039924</ArticleId><ArticleId IdType="pubmed">27312411</ArticleId></ArticleIdList></Reference><Reference><Citation>Patro R., Duggal G., Love M. I., Irizarry R. A., Kingsford C., Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417&#x2013;419 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5600148</ArticleId><ArticleId IdType="pubmed">28263959</ArticleId></ArticleIdList></Reference><Reference><Citation>Soneson C., Love M. I., Robinson M. D., Differential analyses for RNA-seq: Transcript-level estimates improve gene-level inferences. F1000Research 4, 1521 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4712774</ArticleId><ArticleId IdType="pubmed">26925227</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Paggi J. M., Park C., Bennett C., Salzberg S. L., Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907&#x2013;915 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605509</ArticleId><ArticleId IdType="pubmed">31375807</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R.; 1000 Genome Project Data Processing Subgroup , The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078&#x2013;2079 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders S., Pyl P. T., Huber W., HTSeq-A Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166&#x2013;169 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4287950</ArticleId><ArticleId IdType="pubmed">25260700</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Tamayo P., Mootha V. K., Mukherjee S., Ebert B. L., Gillette M. A., Paulovich A., Pomeroy S. L., Golub T. R., Lander E. S., Mesirov J. P., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545&#x2013;15550 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1239896</ArticleId><ArticleId IdType="pubmed">16199517</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed A. I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., Sturn A., Snuffin M., Rezantsev A., Popov D., Ryltsov A., Kostukovich E., Borisovsky I., Liu Z., Vinsavich A., Trush V., Quackenbush J., TM4: A free, open-source system for microarray data management and analysis. Biotechniques 34, 374&#x2013;378 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12613259</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant C. E., Bailey T. L., Noble W. S., FIMO: Scanning for occurrences of a given motif. Bioinformatics 27, 1017&#x2013;1018 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3065696</ArticleId><ArticleId IdType="pubmed">21330290</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrido-Mart&#xed;n D., Palumbo E., Guig&#xf3; R., Breschi A., ggsashimi: Sashimi plot revised for browser- and annotation-independent splicing visualization. PLOS Comput. Biol. 14, e1006360 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6114895</ArticleId><ArticleId IdType="pubmed">30118475</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., Preibisch S., Rueden C., Saalfeld S., Schmid B., Tinevez J. Y., White D. J., Hartenstein V., Eliceiri K., Tomancak P., Cardona A., Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676&#x2013;682 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>